TITLE

Artemether

PUB. DATE
October 2013
SOURCE
Reactions Weekly;10/12/2013, Issue 1473, p8
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
An abstract of the article "Hemolytic anemia in a child with malaria treated with arthemeter," by M. J. Munoz-Vilches and colleagues is presented.
ACCESSION #
90631349

 

Related Articles

  • Short communication: bendamustine-related hemolytic anemia in chronic lymphocytic leukemia. Goldschmidt, Neta; Gural, Alexander; Ben-Yehuda, Dina; Gatt, Moshe // Cancer Chemotherapy & Pharmacology;Sep2013, Vol. 72 Issue 3, p709 

    Purpose: Immune hemolytic anemia (IHA) may complicate the course of chronic lymphocytic leukemia (CLL), especially in patients with advanced disease, and as a complication of treatment with chlorambucil or fludarabine. Bendamustine, a novel agent with both alkylating and purine-analog...

  • Prednisolone.  // Reactions Weekly;10/29/2016, Vol. 1625 Issue 1, p165 

    The article presents a case study of an 80-year-old man, with a history of autoimmune haemolytic anaemia (AIHA), who developed fulminant visceral disseminated varicella-zoster virus (VZV) infection after receiving prednisolone.

  • Quinine.  // Reactions Weekly;11/10/2012, Issue 1427, p40 

    The article describes the cases of two women who developed ocular toxicity during treatment with parenteral quinine for malaria.

  • The Effectiveness of Darbepoetin Alfa Administered Every 3 Weeks on Hematologic Outcomes and Quality of Life in Older Patients With Chemotherapy-Induced Anemia. Boccia, Ralph; Lillie, Tom; Tomita, Dianne; Balducci, Lodovico // Oncologist;May2007, Vol. 12 Issue 5, p584 

    Chemotherapy-induced anemia (CIA) may substantially impact the health-related quality of life (HRQoL) of older cancer patients. This exploratory analysis evaluated the effect of darbepoetin alfa administered as a fixed dose (300 7µg) every 3 weeks (Q3W) on hematologic outcomes, HRQoL, and...

  • Sudden Death in a Traveler Following Halofantrine Administration--Togo, 2000.  // MMWR: Morbidity & Mortality Weekly Report;3/9/2001, Vol. 50 Issue 9, p169 

    Summarizes the findings of an investigation on the sudden death of a student following the use of halofantrine for malaria treatment. Medical background of the student; Precautions for using halofantrine; Side effects of halofantrine.

  • Safety profile of Coartem: the evidence base. Falade, Catherine; Manyando, Christine // Malaria Journal;2009 Supplement 1, Vol. 8, p1 

    This article reviews the comprehensive data on the safety and tolerability from over 6,300 patients who have taken artemether/lumefantrine (Coartem®) as part of Novartis-sponsored or independently-sponsored clinical trials. The majority of the reported adverse events seen in these studies are...

  • Toxicity of antimalarial drugs. Peto, T. E. A. // Journal of the Royal Society of Medicine (Supplement);Jul1989, Vol. 82 Issue 17, p30 

    The article summarises the incidence of major adverse effects of antimalarial drugs and their minor side effects. There have been few reports of severe or fatal adverse effects attributed to the use of chloroquine at the normal prophylactic dose. The drug proguanil was first used in 1948 at a...

  • A prospective study of adverse drug reactions to artemisinin-based combination therapy in a tertiary care hospital in India. Belhekar, Mahesh N.; Advani, Manjari G.; Pawar, Sudhir R. // Indian Journal of Pharmacology;Apr2012, Vol. 44 Issue 2, p257 

    Objectives: Antimalarial drugs are commonly prescribed for the treatment of malaria and suspected cases of malaria in India. The recent trend is to prescribe ACT and the incidence of adverse reactions to this therapy is not-well-documented in Indian population. Therefore, this study was designed...

  • Qualaquin.  // Pharmaceutical Representative;Aug2010, Vol. 40 Issue 8, p11 

    The article reports on the warning issued by the Food and Drug Administration (FDA) that the use of unapproved malaria drug Qualaquin to treat night time leg cramps may result into a serious side effects in the U.S.

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics